phase readout

NCT06830850: A Trial of HRS-5041-103 to Evaluate the Safety, Tolerability, Pharmacokinetics and Efficacy of HRS-5041 in Subjects With Metastatic Castration-resistant Prostate Cancer

RECRUITINGupdated 5d ago

community read0 votes

Sponsor: Atridia Pty Ltd.. Phase: PHASE1. Conditions: Metastatic Castration Resistant Prostate Cancer

Data sources

last refreshed 1h ago

Found something off?

comments(0)

5-min edit window · permanent after that

sign in to leave a comment · permanent archive after 5 minutes

no comments yet — first sniff?